- ... increased risk of osteonecrosis in association with chronic graft-versus-host disease (GVHD).[ 65 , 73 , 79 ] Age at time of diagnosis or transplant. Several studies have demonstrated that age ...
- NLM Digital Collections - The Surgeon General's Workshop on Increasing Organ Donation: Proceedings (pages 1-25)Publication: United States. Public Health Service. Office of the Surgeon General, 1991... transplantation, predominant problems are: acute and chronic rejection, graft vs. host disease, diagnosis of rejection, and the digestive and non-digestive ...
- NLM Digital Collections - The Surgeon General's Workshop on Increasing Organ Donation: ProceedingsPublication: United States. Public Health Service. Office of the Surgeon General, 1991... transplantation, predominant problems are: acute and chronic rejection, graft vs. host disease, diagnosis of rejection, and the digestive and non-digestive ...
- ... at the same time. - Blood product transfusion . - Chronic graft-versus-host ... of time since diagnosis and treatment. - Changes in hormone levels. - The ability ...
- ... Enteritis section of this summary for more information.) Graft-versus-host disease (GVHD) is a major complication of allogeneic transplantation, and the intestinal tract, skin, and liver are commonly affected. Symptoms of gastrointestinal GVHD include nausea and vomiting, severe ...
- ... by abdominal magnetic resonance imaging in acute intestinal graft versus host disease. ... diagnosis of acute appendicitis in child population. Pediatric radiology. ...
- ... the chances of preventing cognitive decline and improving symptoms. However, ... graft-versus-host disease (GVHD) and other long-term and late effects ...
- GVHD; Bone marrow transplant - graft-versus-host disease; Stem cell transplant - graft-versus-host disease; Allogeneic transplant - GVHD ... Elsevier; 2020:chap 28. Reddy P, Ferrara JLM. Graft-versus-host disease and graft-versus-leukemia responses. In: Hoffman R, ...
- NLM Digital Collections - Chimeric antigen receptor T-cell therapy for B-cell cancers : effectiveness and value : final ...Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, March 23, 2018... ALL Systemic infection None Age < 21 years at diagnosis Symptomatic CNS Refractory or in second or subsequent relapse disease ≥ 25% blasts in bone marrow Active graft versus Performance status ≥50% host disease SCT in past 3 months Hijiya 201122 ...
- ... the procedure is performed within 1 year of diagnosis.[ 38 - 40 ][ Level of ... disease (GVHD) and fewer fevers, hospitalizations, and hospital ...
346 results